Clobazam, a 1,5-benzodiazepine, and car-driving ability

British Journal of Clinical Pharmacology
I HindmarchA J Hewett


1 The effects of clobazam, a new anxiolytic agent (a 1,5-benzodiazepine) on car-driving ability and other tests of psychomotor performance were investigated in a double-blind, cross-over study v. placebo in normal volunteers. 2 Clobazam (20 mg) or placebo was given nightly for six nights to ten volunteers and subjective ratings of sleep and subjective and objective assessments of behaviour and psychomotor performance on the morning following drug ingestion were recorded. 3 Clobazam significantly improved the subjective ratings of sleep induction and quality of induced sleep. 4 Clobazam did not significantly impair performance in a variety of psychomotor tests and car-driving ability. 5 The validity of the measures used and the relevance of the findings to real life car-driving situations are discussed.


Oct 1, 1977·British Journal of Clinical Pharmacology·A N NicholsonC H Clarke
Jan 1, 1968·Journal of Clinical Psychology·D T Johnson, C D Spielberger
Dec 9, 1972·British Medical Journal·T A BettsG M Mackay
Jan 1, 1974·Psychopharmacologia·M TansellaM H Lader
Sep 28, 1973·Psychopharmacologia·A J Bond, M H Lader
Mar 1, 1974·Annals of Internal Medicine·L E Hollister
Jan 1, 1970·The British Journal of Psychiatry : the Journal of Mental Science·S CrownR W Howell
Dec 1, 1968·Journal of Consulting and Clinical Psychology·D T Johnson
Sep 1, 1955·Journal of Abnormal Psychology·J E DOPPELT, W L WALLACE
Dec 1, 1974·British Journal of Clinical Pharmacology·T Silverstone


Jan 1, 1982·Psychopharmacology·L C Johnson, D A Chernik
Nov 10, 1978·Zeitschrift für Rechtsmedizin. Journal of legal medicine·G Sticht, H Käferstein
Jan 1, 1979·British Journal of Clinical Pharmacology·B S MeldrumR W Horton
Jan 1, 1979·British Journal of Clinical Pharmacology·B Biehl
Jan 1, 1979·British Journal of Clinical Pharmacology·H H WieckB Heerklotz
Jan 1, 1979·British Journal of Clinical Pharmacology·G W Hanks
Apr 1, 1996·Environmental Health Perspectives·A Wetherell
Jul 1, 1978·British Journal of Clinical Pharmacology·A N Nicholson
Aug 1, 1980·British Journal of Clinical Pharmacology·I Hindmarch, A C Gudgeon
Jul 3, 2018·Psychiatry and Clinical Neurosciences·Mari IwataNorio Ozaki
May 1, 1985·British Journal of Obstetrics and Gynaecology·P OianB Osterud
Jan 5, 2008·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Tinnakorn ChaiworapongsaSonia Hassan
Sep 1, 1980·British Journal of Clinical Pharmacology·I Hindmarch
Jul 1, 1985·British Journal of Clinical Pharmacology·A Patat, P Foulhoux
Mar 1, 1986·Acta Neurologica Scandinavica·P Elsass
Jan 21, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Tharaka DassanayakeAlison Jones
Dec 4, 1989·The Medical Journal of Australia·J W Tiller

Related Concepts

Automobile Driving
Distance Perception
Motor Skills
Anti-Anxiety Effect

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.